{"title":"Serum levels of interleukin (IL)-33 in patients with ischemic heart disease","authors":"M. Khalili","doi":"10.15406/moji.2018.06.00188","DOIUrl":null,"url":null,"abstract":"Objective:It has been reported that cytokines play a crucial role in pathogenesis of different diseases such as cardiovascular diseases. The aim of this study was to evaluated the serum level of IL-33 in patients with ischemic heart disease (IHD) and also clarify its association with traditional risk factors of the disease. \n \n Methods:A total of 300 patients with IHD as having acute myocardial infarction (AMI; n=100), unstable angina (UA; n=100) or stable angina (SA; n=100) and 100 sex- and age- matched healthy subjects as control group (n=100) were enrolled to this cross-sectional, case controlled study. Serum samples were collected from all participants and tested for IL-33 by use of ELISA method. \n \n Results:The mean serum concentration of IL-33 in AMI (103.3319.29 Pg/ml), SA (157.6033.43 Pg/ml) and UA (122.21 22.26 Pg/ml) was significantly higher than that observed in healthy control (61.857.67 Pg/ml). There was no significant difference between patient with or without certain traditional risk factor including hypertensionve patients, dyslipidemic patients, smokinger, obesity e patients and diabetesic patients in the mean serum level of IL-33. \n \n Conclusion:These results showed that the higher serum concentration of IL-33 was associated with IHD. The presence or absence of certain traditional risk factors of IHD did not influence the serum level of cytokines.","PeriodicalId":90928,"journal":{"name":"MOJ immunology","volume":"6 1","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2018-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MOJ immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/moji.2018.06.00188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
Abstract
Objective:It has been reported that cytokines play a crucial role in pathogenesis of different diseases such as cardiovascular diseases. The aim of this study was to evaluated the serum level of IL-33 in patients with ischemic heart disease (IHD) and also clarify its association with traditional risk factors of the disease.
Methods:A total of 300 patients with IHD as having acute myocardial infarction (AMI; n=100), unstable angina (UA; n=100) or stable angina (SA; n=100) and 100 sex- and age- matched healthy subjects as control group (n=100) were enrolled to this cross-sectional, case controlled study. Serum samples were collected from all participants and tested for IL-33 by use of ELISA method.
Results:The mean serum concentration of IL-33 in AMI (103.3319.29 Pg/ml), SA (157.6033.43 Pg/ml) and UA (122.21 22.26 Pg/ml) was significantly higher than that observed in healthy control (61.857.67 Pg/ml). There was no significant difference between patient with or without certain traditional risk factor including hypertensionve patients, dyslipidemic patients, smokinger, obesity e patients and diabetesic patients in the mean serum level of IL-33.
Conclusion:These results showed that the higher serum concentration of IL-33 was associated with IHD. The presence or absence of certain traditional risk factors of IHD did not influence the serum level of cytokines.